Nebula Research & Development LLC
- SEC CIK
- 0001792635
- Latest filing
- May 15, 2026
CATX holding history
Perspective Therapeutics, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CATX overviewAll 13F holders of CATXFull Q1 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −10,770−100.0% | Sold out | Holders |
| Q1 2025 | 10,770 | $22.9K | <0.1% | −11,080−50.7% | Reduced | Holders |
| Q4 2024 | 21,850 | $69.7K | <0.1% | +7,007+47.2% | Added | Holders |
| Q3 2024 | 14,843 | $198.2K | <0.1% | +14,843 | New | Holders |